Urology · Gadsden, AL
NPI
1558328625
Since 2006
Specialty
Urology
Code 208800000X
Group practices
1
Medicare group memberships
Hospitals
4
Hospital affiliations
713 Goodyear Ave
Gadsden, AL, 35903
Phone (256) 492-4040
Groups this clinician bills Medicare through
Medicare paid, 2024
$253K
55,750 services
Medicare patients, 2024
514
Average age 75
Drug cost, 2024
$1.1M
3,897 prescriptions
Company payments, 2025
$732
From 17 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Manish Shah was code J1071 (injection, testosterone cypionate, 1 mg), 45,220 times for 21 patients. In total Manish Shah billed 55,750 services in 104 codes, and Medicare paid $253K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2023-09-13.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| J1071 Injection, testosterone cypionate, 1 mg | Office | 45,220 | 21 | $0.02 | $825 |
| 84311 Immunoassay | Office | 1,182 | 292 | $7.84 | $9,263 |
| 99214 Office E&M - Established | Office | 777 | 361 | $85.88 | $67K |
| 84580 Clinical Chemistry | Office | 591 | 292 | $9.24 | $5,463 |
| 82945 Clinical Chemistry | Office | 590 | 292 | $3.82 | $2,252 |
| 83069 Blood Count | Office | 590 | 292 | $3.84 | $2,263 |
| 84156 Clinical Chemistry | Office | 590 | 292 | $3.57 | $2,105 |
| 82010 Clinical Chemistry | Office | 589 | 292 | $7.92 | $4,665 |
| 82247 Clinical Chemistry | Office | 589 | 292 | $4.88 | $2,872 |
| 81007 Clinical Chemistry | Office | 588 | 292 | $29.11 | $17K |
| 82043 Clinical Chemistry | Office | 583 | 289 | $5.59 | $3,257 |
| 51798 Ultrasound - Nonspecific | Office | 561 | 313 | $6.99 | $3,921 |
| 81003 Clinical Chemistry | Office | 396 | 216 | $2.14 | $847 |
| 36415 Venipuncture Blood Collection | Office | 342 | 228 | $7.78 | $2,660 |
| 84153 Clinical Chemistry | Office | 339 | 238 | $17.32 | $5,872 |
By year: 2022 $264K for 64,585 services; 2023 $248K for 54,858 services; 2024 $253K for 55,750 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 84311 Immunoassay | 1,182 | 292 | $7.84 | $9,263 |
| 84580 Clinical Chemistry | 591 | 292 | $9.24 | $5,463 |
| 84156 Clinical Chemistry | 590 | 292 | $3.57 | $2,105 |
| 82945 Clinical Chemistry | 590 | 292 | $3.82 | $2,252 |
| 83069 Blood Count | 590 | 292 | $3.84 | $2,263 |
| 82247 Clinical Chemistry | 589 | 292 | $4.88 | $2,872 |
| 82010 Clinical Chemistry | 589 | 292 | $7.92 | $4,665 |
| 81007 Clinical Chemistry | 588 | 292 | $29.11 | $17K |
| 82043 Clinical Chemistry | 583 | 289 | $5.59 | $3,257 |
| 81003 Clinical Chemistry | 396 | 216 | $2.14 | $847 |
Medicare prescription drug claims, 2024
In 2024, the drug Manish Shah prescribed most often to Medicare patients was Tamsulosin Hcl, with 993 prescriptions and refills. In total Manish Shah wrote 3,897 Medicare prescriptions that cost $1.1M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Tamsulosin Hcl Generic | 993 | 2,542 | 299 | $17K |
| Dutasteride Generic | 682 | 1,678 | 188 | $33K |
| Myrbetriq Mirabegron | 283 | 353 | 57 | $153K |
| Levofloxacin Generic | 270 | 270 | 203 | $549 |
| Oxybutynin Chloride Er Oxybutynin Chloride | 183 | 465 | 52 | $5,640 |
| Gemtesa Vibegron | 178 | 230 | 47 | $107K |
| Nitrofurantoin Nitrofurantoin Macrocrystal | 168 | 250 | 44 | $7,477 |
| Solifenacin Succinate Generic | 148 | 334 | 50 | $7,674 |
| Oxycodone-Acetaminophen Oxycodone Hcl/Acetaminophen | 109 | 109 | 84 | $660 |
| Finasteride Generic | 79 | 221 | 28 | $1,573 |
| Hydrocodone-Acetaminophen Hydrocodone/Acetaminophen | 73 | 73 | 66 | $344 |
| Trimethoprim Generic | 69 | 137 | 21 | $4,323 |
| Silodosin Generic | 65 | 151 | 22 | $6,463 |
| Nitrofurantoin Mono-Macro Nitrofurantoin Monohyd/M-Cryst | 61 | 81 | 47 | $1,359 |
| Estradiol Generic | 60 | 172 | 39 | $6,040 |
Brand drugs: 616 claims; generic drugs: 3,281 claims; opioid claims: 184.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Manish Shah $732 ($732 in general payments such as food, travel and fees) from 17 companies. The largest payer was Ferring Pharmaceuticals Inc. with $144.
| Company | Payments | Amount |
|---|---|---|
| Ferring Pharmaceuticals Inc. | 7 | $144 |
| Sumitomo Pharma America, Inc. 4506.T | 3 | $67.99 |
| Medtronic, Inc. MDT | 2 | $64.39 |
| Janssen Biotech, Inc. JNJ | 3 | $57.47 |
| Ethicon US, LLC JNJ | 1 | $44.13 |
| Urogen Pharma, Inc. URGN | 2 | $41.35 |
| Accord Healthcare, Inc. | 1 | $40.71 |
| Olympus America Inc. | 2 | $40.53 |
| Coloplast Corp | 1 | $39.69 |
| Bayer Healthcare Pharmaceuticals Inc. BAYN.DE | 2 | $37.57 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.